These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 32021319)

  • 21. Isolation and Characterization of Novel Lytic Phages Infecting Multidrug-Resistant Escherichia coli.
    Vera-Mansilla J; Sánchez P; Silva-Valenzuela CA; Molina-Quiroz RC
    Microbiol Spectr; 2022 Feb; 10(1):e0167821. PubMed ID: 35171030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bacteriophages as Therapeutic and Prophylactic Means: Summary of the Soviet and Post Soviet Experiences.
    Chanishvili N
    Curr Drug Deliv; 2016; 13(3):309-23. PubMed ID: 27090515
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Basic Guidelines for Bacteriophage Isolation and Characterization.
    Samir S
    Recent Pat Biotechnol; 2023; 17(4):312-331. PubMed ID: 36263478
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bacteriophages: The promising therapeutic approach for enhancing ciprofloxacin efficacy against bacterial infection.
    Shariati A; Noei M; Chegini Z
    J Clin Lab Anal; 2023 May; 37(9-10):e24932. PubMed ID: 37377167
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treating bacterial infections with bacteriophages in the 21st century.
    Opperman CJ; Wojno JM; Brink AJ
    S Afr J Infect Dis; 2022; 37(1):346. PubMed ID: 35399556
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bacteriophages: A Therapy Concept against Multi-Drug-Resistant Bacteria.
    Rohde C; Wittmann J; Kutter E
    Surg Infect (Larchmt); 2018; 19(8):737-744. PubMed ID: 30256176
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isolation, characterization, therapeutic potency, and genomic analysis of a novel bacteriophage vB_KshKPC-M against carbapenemase-producing Klebsiella pneumoniae strains (CRKP) isolated from Ventilator-associated pneumoniae (VAP) infection of COVID-19 patients.
    Mohammadi M; Saffari M; Siadat SD; Hejazi SH; Shayestehpour M; Motallebi M; Eidi M
    Ann Clin Microbiol Antimicrob; 2023 Feb; 22(1):18. PubMed ID: 36829156
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bacteriophages and antibiotic interactions in clinical practice: what we have learned so far.
    Łusiak-Szelachowska M; Międzybrodzki R; Drulis-Kawa Z; Cater K; Knežević P; Winogradow C; Amaro K; Jończyk-Matysiak E; Weber-Dąbrowska B; Rękas J; Górski A
    J Biomed Sci; 2022 Mar; 29(1):23. PubMed ID: 35354477
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successful Bacteriophage-Antibiotic Combination Therapy against Multidrug-Resistant
    Racenis K; Lacis J; Rezevska D; Mukane L; Vilde A; Putnins I; Djebara S; Merabishvili M; Pirnay JP; Kalnina M; Petersons A; Stradins P; Maurins S; Kroica J
    Viruses; 2023 May; 15(5):. PubMed ID: 37243293
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bacteriophages and Their Host Range in Multidrug-Resistant Bacterial Disease Treatment.
    Chung KM; Liau XL; Tang SS
    Pharmaceuticals (Basel); 2023 Oct; 16(10):. PubMed ID: 37895938
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of Phages to Treat Antimicrobial-Resistant
    Khan MAS; Rahman SR
    Vet Sci; 2022 Aug; 9(8):. PubMed ID: 36006353
    [No Abstract]   [Full Text] [Related]  

  • 32. Phage-based therapy against biofilm producers in gram-negative ESKAPE pathogens.
    Ragupathi NKD; Muthuirulandi Sethuvel DP; Gopikrishnan M; Dwarakanathan HT; Murugan D; Biswas I; Bakthavachalam YD; Murugesan M; George Priya Doss C; Monk PN; Karunakaran E; Veeraraghavan B
    Microb Pathog; 2023 May; 178():106064. PubMed ID: 36898591
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isolation and Characterization of Novel Phages Targeting Pathogenic
    Li N; Zeng Y; Bao R; Zhu T; Tan D; Hu B
    Front Cell Infect Microbiol; 2021; 11():792305. PubMed ID: 34926329
    [No Abstract]   [Full Text] [Related]  

  • 34. Bacteriophage genome engineering for phage therapy to combat bacterial antimicrobial resistance as an alternative to antibiotics.
    Usman SS; Uba AI; Christina E
    Mol Biol Rep; 2023 Aug; 50(8):7055-7067. PubMed ID: 37392288
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical Pharmacology of Bacteriophage Therapy: A Focus on Multidrug-Resistant
    Holger D; Kebriaei R; Morrisette T; Lev K; Alexander J; Rybak M
    Antibiotics (Basel); 2021 May; 10(5):. PubMed ID: 34064648
    [No Abstract]   [Full Text] [Related]  

  • 36. Characterization of
    Tan D; Zhang Y; Cheng M; Le S; Gu J; Bao J; Qin J; Guo X; Zhu T
    Viruses; 2019 Nov; 11(11):. PubMed ID: 31752386
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Biological characteristics and genomic information of a bacteriophage against pan-drug resistant
    Qi ZY; Yang SY; Dong SW; Zhao FF; Qin JH; Xiang J
    Zhonghua Shao Shang Za Zhi; 2020 Jan; 36(1):14-23. PubMed ID: 32023713
    [No Abstract]   [Full Text] [Related]  

  • 38. Bacteriophage isolated from non-target bacteria demonstrates broad host range infectivity against multidrug-resistant bacteria.
    Ngiam L; Schembri MA; Weynberg K; Guo J
    Environ Microbiol; 2021 Sep; 23(9):5569-5586. PubMed ID: 34390602
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and Evaluation of Bacteriophage Cocktail to Eradicate Biofilms Formed by an Extensively Drug-Resistant (XDR)
    Vashisth M; Jaglan AB; Yashveer S; Sharma P; Bardajatya P; Virmani N; Bera BC; Vaid RK; Anand T
    Viruses; 2023 Feb; 15(2):. PubMed ID: 36851640
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Post-Antibiotic Era: A New Dawn for Bacteriophages.
    Jin Y; Li W; Zhang H; Ba X; Li Z; Zhou J
    Biology (Basel); 2023 May; 12(5):. PubMed ID: 37237494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.